Mira Pharmaceuticals (MIRA) Market Cap (2023 - 2026)
Mira Pharmaceuticals (MIRA) market cap from Aug 3, 2023 to Jun 2, 2026. The current Mira Pharmaceuticals (MIRA) market cap is $44M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Market Cap
Mira Pharmaceuticals (MIRA) Market Cap CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +116.51% |
| All Time TTM | +20.90% |
Annual Market Cap change of Mira Pharmaceuticals (MIRA)
| Year | Market Cap | Change |
|---|---|---|
| 2026 | $44M | -30.99% |
| 2025 | $63M | +235.43% |
| 2024 | $19M | +21.65% |
| 2023 | $16M | N/A |
Comparison Mira Pharmaceuticals (MIRA) market cap with competitors
Mira Pharmaceuticals (MIRA) market cap is $43.70M.
| Ticker | Name | Market Cap | Upside |
|---|---|---|---|
| LLY | Lilly(Eli) & Company | $969.83B | +2219050.73% |
| JNJ | Johnson & Johnson | $557.13B | +1274715.66% |
| ABBV | Abbvie Inc | $381.28B | +872325.14% |
| MRK | Merck & Co Inc | $297.23B | +680021.46% |
| AZN | Astrazeneca plc | $289.83B | +663083.46% |
| NVS | Novartis AG | $289.55B | +662431.44% |
| NVO | Novo Nordisk | $198.19B | +453392.25% |
| AMGN | AMGEN Inc | $181.37B | +414909.74% |
| GILD | Gilead Sciences Inc | $166.04B | +379835.23% |
| PFE | Pfizer Inc | $149.16B | +341206.57% |
| BMY | Bristol-Myers Squibb Company | $117.25B | +268179.57% |
| SNY | Sanofi | $107.01B | +244746.54% |
| GSK | GSK Plc | $105.07B | +240314.92% |
| BIIB | Biogen Inc | $28.99B | +66243.28% |
| GRFS | Grifols SA | $5.48B | +12436.06% |
| OGN | Organon & Company | $3.51B | +7941.20% |
| AMRN | Amarin Corp | $304.63M | +597.04% |
| SCLX | Scilex Holding Company | $57.83M | +32.31% |
| NSRX | Nasus Pharma Ltd | $27.23M | -37.70% |
| MDCXW | Medicus Pharma Ltd warrant | $14.00M | -67.97% |
| MDCX | MDCorp | $12.34M | -71.77% |